Clinical practice of traditional Chinese medicine for the treatment of postmenopausal osteoporosis: a literature review

References

• Kanis JA, Kanis JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int. 1994;4(6):3683–81.
   Web of Science ®Google Scholar
• NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy, march 7–29, 2000: highlights of the conference. South Med J. 2001;94(6):569–573.
   PubMedGoogle Scholar
• Xia W, Zhang Z, Lin H, et al. Guidelines for the diagnosis and treatment of primary osteoporosis (2017). Chinese Journal of Osteoporosis. 2019;25(3):281–309.
   Google Scholar
• Svedbom A, Hernlund E, Ivergård M, et al. Osteoporosis in the european union: a compendium of country-specific reports. Arch Osteoporos. 2013;8(1):137.
   PubMed Web of Science ®Google Scholar
• Wade SW, Strader C, Fitzpatrick LA, et al. Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos. 2014;9:182.
   PubMed Web of Science ®Google Scholar
• Nelson R, Willson T, Nelson S, et al. The clinical epidemiology of male osteoporosis: a review of the recent literature. CLEP. 2015;7:65–76.
   Google Scholar
• Kanis JA, Cooper C, Rizzoli R, et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3–44.
   PubMed Web of Science ®Google Scholar
• Lee E, Kim J, Kim Y, et al. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice. Phytomedicine. 2014;21(10):1208–1215.
   PubMed Web of Science ®Google Scholar
• Almeida M, Laurent MR, Dubois V, et al. Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev. 2017;97(1):135–187.
   PubMed Web of Science ®Google Scholar
• Meng-Meng Z. Estrogen and estrogen receptors on bone metabolism regulation. Chin J Osteoporo. 2019;25(5):704–708.
   Google Scholar
• Compston JE, Mcclung MR, Leslie WD. Osteoporosis. Lancet. 2019;393(10169):364–376.
   PubMed Web of Science ®Google Scholar
• Tang S, Shen D, Lu P, et al. Advances in researches made via traditional chinese medicine inheritance support system. China J Tradit Chin Med Pharm. 2015;30(2):329–331.
   Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
   PubMedGoogle Scholar
• Zhang F, Shi Q. Chinese medicine treatment of osteoporosis in postmenopausal women. Informa Tradit Chin Med. 1993;1993(3):46.
   Google Scholar
• Zhang Z, Liu Z, Li N, et al. Expert consensus on the diagnosis of osteoporosis in Chinese population. Chin J Osteoporo. 2014;20(9):1007–1010.
   Google Scholar
• Liu Z, Yang D, Zhu H, et al. Recommended diagnostic criteria for osteoporosis in chinese (the second draft). Chin J Osteoporo. 2000;6(1):1–3.
   Google Scholar
• Zheng X. Guiding principles for clinical research of new chinese medicines. Beijing: China Medical Science Press; 2002. p. 356–360.
   Google Scholar
• Deng W, Shen Y, He Y, et al. Influences of bushen zhuanggu granule on contents of sexual hormones and metabolism of calcium and phosphorous in early menopausal women. J Guangzhou Univ Trad Chin Med. 2001;18(4):301–303.
   Google Scholar
• Zhang R, Chen K, Lu D, et al. A clinical study of Yigu capsule in treating postmenopausal osteoporosis. Chin J Integrat Med. 2005;11(2):97–103.
   PubMedGoogle Scholar
• Deng W, Shao Y, Zhang J, et al. Effect of Bushen Zhuanggu granule on relieving pain in menopausal osteoporosis patients. J Guangzhou Univ Trad Chin Med. 2007;24(5):355–358.
   Google Scholar
• Xiong Y, Teng W, Liu T, et al. Jiangu granules in treatment of postmenopausal osteoporosis: a randomized, double-blind, double dummy, multicenter clinical trial. Chin J Trad Med Traumatol Orthoped. 2008;16(4):17–19.
   Google Scholar
• Liang Y, Wu W, Hou L. Effect analysis of compound Danshen tablets plus alendronate in treatment of women with postmenopausal osteoporosis. Chin J Pract Nurs. 2011;27(18):29–31.
   Google Scholar
• Li J. A randomized, double-blind, placebocontroled clinical study on Bushenhuoxuetang granuilreatment for postmenopausal osteoporosis.China: China Academy of Chinese Medical Sciences; 2012.
   Google Scholar
• Xiang K, Zhuang Q, Huang Y, et al. Clinical study of duhuojisheng decoction combined with zoledronic acid in the treatment of postmenopausal osteoporosis with deficiency of liver and kidney. J Guiyang Coll Tradit Chin Med. 2013;35(4):27–30.
   Google Scholar
• Du Y, Wu Y, Duan Y, et al. Clinical observation of Gushu granule in treating postmenopausal osteoporosis. J New Chin Med. 2013;45(8):76–78.
   Google Scholar
• Li T. Clinical study on modified liuwei dihuang pills in treating postmenopausal osteoporosis with liver and kidney yin deficiency. J Med Forum. 2014;35(8):160–162.
   Google Scholar
• Zhang Y. Study on effectiveness of supplemented six-ingredient rehmannia pill treating liver and kidney yin deficiency and postmenopausal osteoporosis. Sichuan: Luzhou Medical College; 2014.
   Google Scholar
• Yong-Chao X. Clinical osteoporosis (liver and kidney insufficiency) treatment of postmenopausal bone atrophy capsules. Changchun: Changchun University of Chinese Medicine; 2016.
   Google Scholar
• Guo Q, Zhao H, Lei X, et al. Clinical observation on treatment of postmenopausal osteoporosis with syndrome differentiation and treatment. Lishizhen Med Materia Medica Res. 2016;27(8):1920–1922.
   Google Scholar
• Bian Q. Study on tongue parameters of postmenopausal osteoporosis with kidney deficiency and blood stasis syndrome and intervention of Qing’e pill. Wuhan: Hubei University of Chinese Medicine; 2016.
   Google Scholar
• Wang W, Lu Q, Ren Q, et al. Clinical observation on gengnian jianshen decoction (GJD) in the treatment of postmenopausal osteoporosis with deficiency of liver-yin and kidney-yin syndrome. World Chin Med. 2018;13(4):889–892.
   Google Scholar
• Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007;356(18):1809–1822.
   PubMed Web of Science ®Google Scholar
• Shannon J, Shannon J, Modelevsky S, et al. Bisphosphonates and osteonecrosis of the jaw. J Am Geriatr Soc. 2011;59(12):2350–2355.
   PubMed Web of Science ®Google Scholar
• Wang S, Chen C, Zhang W, et al. Experimental study of epimedium medicated serum on the expression of Sirt1 mRNA and PPARγ mRNA in the BMSCs of rats with osteoporosis. Trad Chin Drug Res Clin Pharma. 2019;30(3):296–300.
   Google Scholar
• Kim B, Lee KY, Park B. Icariin abrogates osteoclast formation through the regulation of the RANKL-mediated TRAF6/NF-kappaB/ERK signaling pathway in Raw264.7 cells. Phytomedicine. 2018;51:181–190.
   PubMed Web of Science ®Google Scholar
• Cai Y, Zhang X. Protective effect of Rhizoma drynariae extract on osteoporosis in ovariectomized rat model. Trop J Pharm Res. 2016;15(7):1447–1452.
   Web of Science ®Google Scholar
• Yan C, Zhang S, Wang C, et al. A fructooligosaccharide from achyranthes bidentata inhibits osteoporosis by stimulating bone formation. Carbohydr Polym. 2019;210:110–118.
   PubMed Web of Science ®Google Scholar
• Li F, Yang X, Bi J, et al. Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats. Pharm Biol. 2016;54(9):1857–1864.
   PubMed Web of Science ®Google Scholar
• Qin L, Han T, Zhang Q, et al. Antiosteoporotic chemical constituents from Er-Xian decoction, a traditional Chinese herbal formula. J Ethnopharmacol. 2008;118(2):271–279.
   PubMed Web of Science ®Google Scholar
• Zhou LP, Wong KY, Yeung HT, et al. Bone protective effects of Danggui Buxue tang alone and in combination with tamoxifen or raloxifene in vivo and in vitro. Front Pharmacol. 2018;9:779.
   PubMed Web of Science ®Google Scholar
• Balk EM, Adam GP, Langberg VN, et al. Global dietary calcium intake among adults: a systematic review. Osteoporos Int. 2017;28(12):3315–3324.
   PubMed Web of Science ®Google Scholar
• Yang C, Mao M, Ping L, et al. Prevalence of vitamin D deficiency and insufficiency among 460,537 children in 825 hospitals from 18 provinces in mainland China. Medicine. 2020;99(44):e22463.
   PubMed Web of Science ®Google Scholar